Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/18806
Title: | The phenotype of SCN8A developmental and epileptic encephalopathy. | Austin Authors: | Gardella, Elena;Marini, Carla;Trivisano, Marina;Fitzgerald, Mark P;Alber, Michael;Howell, Katherine B;Darra, Francesca;Siliquini, Sabrina;Bölsterli, Bigna K;Masnada, Silva;Pichiecchio, Anna;Johannesen, Katrine M;Jepsen, Birgit;Fontana, Elena;Anibaldi, Gaia;Russo, Silvia;Cogliati, Francesca;Montomoli, Martino;Specchio, Nicola;Rubboli, Guido;Veggiotti, Pierangelo;Beniczky, Sandor;Wolff, Markus;Helbig, Ingo;Vigevano, Federico;Scheffer, Ingrid E ;Guerrini, Renzo;Møller, Rikke S | Affiliation: | Universitätskinderklinik Tübingen, Germany Department of Clinical Neurophysiology, Danish Epilepsy Centre, Dianalund, Denmark Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark Neuroscience Department, Children's Hospital A. Meyer, University of Florence, Italy Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, USA Departments of Pediatrics and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia Department of Neurology, Royal Children's Hospital Melbourne, Melbourne, Australia Department of Paediatrics, University of Melbourne, Melbourne, Australia Australia Neurosciences Group, Murdoch Children's Research Institute, Melbourne, Australia Servizio di Neuropsichiatria Infantile, Policlinico G.B. Rossi, Universita Degli Studi di Verona, Italy Department of Child Neurology, Ospedale Pediatrico G. Salesi-Ospedali Riuniti, Ancona, Italy Division of Clinical Neurophysiology, Children's Research Center, University Children's Hospital Zurich, Switzerland Brain and Behaviour Department, University of Pavia, Pavia, Italy Department of Pediatric Neuroradiology, IRCCS "C. Mondino" National Neurological Institute, Pavia, Italy Department of Epilepsy Genetics, Danish Epilepsy Centre Dianalund, Dianalund, Denmark Department of Child Neurology, Danish Epilepsy Centre, Dianalund, Denmark Cytogenetic and Molecular Genetic Laboratory, Istituto Auxologico Italiano, IRCCS, Milano, Italy Department of Adult Neurology, Danish Epilepsy Centre, Dianalund, Denmark University of Copenhagen, Denmark Struttura Complessa di Neurologia Pediatrica Ospedale Vittore Buzzi, Milano, Italy Dipartimento di Scienze Biomediche e Cliniche L. Sacco, Università di Milano, Italy Århus University, Denmark Department of Child Neurology, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia The Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia Department of Child Neurology, The Royal Children's Hospital, Melbourne, Australia |
Issue Date: | 31-Aug-2018 | Date: | 2018-08-31 | Publication information: | Neurology 2018; 91(12): e1112-e1124 | Abstract: | To delineate the electroclinical features of SCN8A infantile developmental and epileptic encephalopathy (EIEE13, OMIM #614558). Twenty-two patients, aged 19 months to 22 years, underwent electroclinical assessment. Sixteen of 22 patients had mildly delayed development since birth. Drug-resistant epilepsy started at a median age of 4 months, followed by developmental slowing, pyramidal/extrapyramidal signs (22/22), movement disorders (12/22), cortical blindness (17/22), sialorrhea, and severe gastrointestinal symptoms (15/22), worsening during early childhood and plateauing at age 5 to 9 years. Death occurred in 4 children, following extreme neurologic deterioration, at 22 months to 5.5 years. Nonconvulsive status epilepticus recurred in 14 of 22 patients. The most effective antiepileptic drugs were oxcarbazepine, carbamazepine, phenytoin, and benzodiazepines. EEG showed background deterioration, epileptiform abnormalities with a temporo-occipital predominance, and posterior delta/beta activity correlating with visual impairment. Video-EEG documented focal seizures (FS) (22/22), spasm-like episodes (8/22), cortical myoclonus (8/22), and myoclonic absences (1/22). FS typically clustered and were prolonged (<20 minutes) with (1) cyanosis, hypomotor, and vegetative semiology, sometimes unnoticed, followed by (2) tonic-vibratory and (3) (hemi)-clonic manifestations ± evolution to a bilateral tonic-clonic seizure. FS had posterior-temporal/occipital onset, slowly spreading and sometimes migrating between hemispheres. Brain MRI showed progressive parenchymal atrophy and restriction of the optic radiations. SCN8A developmental and epileptic encephalopathy has strikingly consistent electroclinical features, suggesting a global progressive brain dysfunction primarily affecting the temporo-occipital regions. Both uncontrolled epilepsy and developmental compromise contribute to the profound impairment (increasing risk of death) during early childhood, but stabilization occurs in late childhood. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/18806 | DOI: | 10.1212/WNL.0000000000006199 | ORCID: | 0000-0002-2311-2174 | Journal: | Neurology | PubMed URL: | 30171078 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.